CIK 0000749647 · Non-accelerated filer<br>Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521256615
- Phone
- (609) 896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- 4 Grant or award President and CEO acquired 6,822 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 3,626 shares (grant or award)
- 4 Open-market sale General Counsel and Corp Sec sold 2,525 shares at $1.56 ($3,950)
- 4 Grant or award President and CEO acquired 6,615 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 3,516 shares (grant or award)
- 4 Grant or award Executive Chairman of Board acquired 7,147 shares (grant or award)
- 4 Open-market sale General Counsel and Corp Sec sold 2,449 shares at $1.63 ($3,993)
- 4 Grant or award Director acquired 6,934 shares (grant or award)
- 4 Grant or award Director acquired 6,934 shares (grant or award)
- 4 Grant or award Director acquired 6,934 shares (grant or award)
- 4 Grant or award Director acquired 6,180 shares (grant or award)
- 4 Open-market sale General Counsel and Corp Sec sold 2,541 shares at $1.57 ($3,977)
- 4 Grant or award Executive Chairman of Board acquired 6,358 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 3,649 shares (grant or award)
- 4 Grant or award President and CEO acquired 5,010 shares (grant or award)
- 4 Grant or award Executive Chairman of Board acquired 4,603 shares (grant or award)
- 4 Open-market sale General Counsel and Corp Sec sold 2,150 shares at $1.78 ($3,830)
- 4 Grant or award Chief Medical Officer acquired 3,082 shares (grant or award)
- 4 Grant or award President and CEO acquired 4,907 shares (grant or award)
- 4 Grant or award Executive Chairman of Board acquired 4,410 shares (grant or award)
Page 2 of 30 · 594 filings